Gupta, Shiva http://orcid.org/0000-0002-4758-8118
Kang, Hyunseon C.
Sun, Jia
Matrana, Marc R.
Tannir, Nizar M.
Choi, Haesun
Funding for this research was provided by:
National Cancer Institute (P30CA016672)
Article History
First Online: 10 December 2019
Compliance with ethical standards
:
: Shiva Gupta, MD; Hyunseon Christine Kang, MD PhD; Jia Sun, PhD; and Haesun Choi, MD have no disclosures. Marc R. Matrana, MD—Speaker’s Bureau: BMS, AstraZeneca, Janssen, Genentech, Eisai, Merck; Consultant: Strata Oncology, AstraZeneca. No funding was received for this study. Nizar M. Tannir, MD—Honoraria: Pfizer, Novartis, Bristol-Myers Squibb, Exelixis, Nektar; Calithera Biosciences, Eisai Medical Research, Ono Pharmaceutical; Consultant: Novartis; Exelixis, BMS, Nektar, Pfizer, Eisai, Calithera Biosciences Inc., Ono Pharmaceutical, Oncorena. Research Funding: BMS, Novartis, Exelixis, Epizyme, Mirati Therapeutics. No funding was received for this study.